CLINICAL_TRIALS
trial_result
· 2012-11-01
Clinical Trial Update: A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis [Phase 3]
Summary
A Phase 3 study of tocilizumab in active polyarticular juvenile idiopathic arthritis has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-01